Guggenheim lowered the firm’s price target on Cognizant (CTSH) to $80 from $85 and keeps a Buy rating on the shares. Q1 results “proved that few, if any, are immune to ongoing complexity in the demand environment,” the analyst tells investors. While the Q2 outlook signals near-term prudence in the wake of elevated levels of uncertainty, the outlook “also signals a shift in philosophy,” the analyst added.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTSH:
- Cognizant price target lowered to $58 from $68 at Citi
- Cognizant’s Costly ‘Project Leap’: Restructuring Push Raises Risks to Productivity, Profitability, and Competitive Position
- Cognizant Earnings Call: Bookings Shine Amid Margin Strain
- Cognizant price target lowered to $75 from $80 at Goldman Sachs
- Maggie Nolan Reiterates Buy on Cognizant as Large Deals, Acquisitions and Project Leap Drive Earnings and Margin Upside Potential
